KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Net Margin (2016 - 2025)

Globus Medical (GMED) has disclosed Net Margin for 15 consecutive years, with 17.01% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 1298.0% year-over-year to 17.01%, compared with a TTM value of 18.3% through Dec 2025, up 1421.0%, and an annual FY2025 reading of 18.3%, up 1421.0% over the prior year.
  • Net Margin was 17.01% for Q4 2025 at Globus Medical, up from 15.47% in the prior quarter.
  • Across five years, Net Margin topped out at 27.22% in Q2 2025 and bottomed at 71.84% in Q4 2022.
  • Average Net Margin over 5 years is 8.79%, with a median of 15.99% recorded in 2022.
  • The sharpest move saw Net Margin crashed -7788bps in 2022, then skyrocketed 7428bps in 2023.
  • Year by year, Net Margin stood at 6.04% in 2021, then crashed by -1289bps to 71.84% in 2022, then surged by 103bps to 2.44% in 2023, then soared by 65bps to 4.03% in 2024, then skyrocketed by 322bps to 17.01% in 2025.
  • Business Quant data shows Net Margin for GMED at 17.01% in Q4 2025, 15.47% in Q3 2025, and 27.22% in Q2 2025.